Association between promoter -1607 polymorphism of <it>MMP1 </it>and Lumbar Disc Disease in Southern Chinese

1471-2350-9-38 1471-2350 Research article Association between promoter -1607 polymorphism of <it>MMP1 </it>and Lumbar Disc Disease in Southern Chinese Song You-Qiang songy@hku.hk Ho WH Daniel dwhho@hku.hk Karppinen Jaro jaro.karppinen@ttl.fi Kao YP Patrick patrickkao@hku.hk Fan Bao-Jian bao-jian_fan@meei.harvard.edu Luk DK Keith hrmoldk@hku.hk Yip Shea-Ping htspyip@smtp7.polyu.edu.hk Leong CY John jcyleong@ouhk.edu.hk Cheah SE Kathryn hrmbdkc@hkusua.hku.hk Sham Pak pcsham@hku.hk Chan Danny chand@hkusua.hku.hk Cheung MC Kenneth cheungmc@hku.hk

Department of Biochemistry, University of Hong Kong, Hong Kong, China

Department of Orthopaedics and Traumatology, University of Hong Kong, Hong Kong, China

Department of Rehabilitation, University of Oulu, Oulu, Finland

Department of Health Technology and Informatics, The Hong Kong Polytechnic University, Hong Kong, China

Department of Psychiatry, University of Hong Kong, Hong Kong, China

Open University of Hong Kong, Hong Kong, China

BMC Medical Genetics 1471-2350 2008 9 1 38 http://www.biomedcentral.com/1471-2350/9/38 18439317 10.1186/1471-2350-9-38 30 11 2007 28 4 2008 28 4 2008 2008 Song et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Background

Matrix metalloproteinases (MMPs) are involved in the degradation of the extracellular matrix of the intervertebral disc. A SNP for guanine insertion/deletion (G/D), the -1607 promoter polymorphism, of the MMP1 gene was found significantly affecting promoter activity and corresponding transcription level. Hence it is a good candidate for genetic studies in DDD.

Methods

Southern Chinese volunteers between 18 and 55 years were recruited from the population. DDD in the lumbar spine was defined by MRI using Schneiderman's classification. Genomic DNA was isolated from the leukocytes and genotyping was performed using the Sequenom^®platform. Association and Hardy-Weinberg equilibrium checking were assessed by Chi-square test and Mann-Whitney U test.

Results

Our results showed substantial evidence of association between -1607 promoter polymorphism of MMP1 and DDD in the Southern Chinese subjects. D allelic was significantly associated with DDD (p value = 0.027, odds ratio = 1.41 with 95% CI = 1.04–1.90) while Genotypic association on the presence of D allele was also significantly associated with DDD (p value = 0.046, odds ratio = 1.50 with 95% CI = 1.01–2.24). Further age stratification showed significant genotypic as well as allelic association in the group of over 40 years (genotypic: p value = 0.035, odds ratio = 1.617 with 95% CI = 1.033–2.529; allelic: p value = 0.033, odds ratio = 1.445 with 95% CI = 1.029–2.029). Disc bulge, annular tears and the Schmorl's nodes were not associated with the D allele.

Conclusion

We demonstrated that individuals with the presence of D allele for the -1607 promoter polymorphism of MMP1 are about 1.5 times more susceptible to develop DDD when compared with those having G allele only. Further association was identified in individuals over 40 years of age. Disc bulge, annular tear as well as Schmorl's nodes were not associated with this polymorphism.

Background

Low back pain (LBP) affects 70% to 80% of all people at some time during their life 1. The annual prevalence ranges from 15% to 45%, with a point prevalence averaging 30% 1. Degenerative Disc Disease (DDD) in the lumbar spine or lumbar disc degeneration is a major cause of LBP 234567.

Up to now, there is only a limited understanding of DDD, with the underlying pathophysiological and molecular mechanisms remain un-elucidated. Studies suggested that environmental factors such as physical loading, motor vehicle driving, vibration and smoking may have a role 891011. However, there is increasing evidence that DDD is a genetic disorder 12, with reports of predisposition in association with certain genes, such as Taq I polymorphism of vitamin D receptor (VDR) gene 251314, polymorphism of metalloproteinase-3 (MMP3) gene 151617, mutations in collagen IX genes (COL9A2 and COL9A3) 1819202122, Sp1 polymorphism of collagen I gene (COL1A1) 2324, polymorphism of cartilage intermediate layer protein (CILP) 25 as well as aggrecan gene polymorphism 26. The involvement of multiple genes is not uncommon, as aetiology is often multifactorial in common diseases such as DDD 12.

In the process of disc degeneration, degradation of the extracellular matrix (ECM) is a key event. Collagens are one of the major constituents of the ECM. They make up 20% dry mass of the nucleus pulposus and 60% dry mass of the annulus fibrosis. Approximately 80% of the collagens in the intervertebral disc consist of fibrillar collagen types I and II 1627. Matrix metalloproteinases (MMPs) are the family of degradation enzymes that break down the components of the ECM 172728. In particular, MMP1 is a collagenase which cleaves the triple helical part of the fibrillar collagen of types I, II and III, and is proposed to initiate the degradation process 29303132333435. The cleaved fragments have a lower melting temperature than 37°C, which are then further cleaved by other MMPs. Similarly, MMP1 can cleave aggrecan at the major MMP cleavage sites between the G1 and G2 domains contributing to the breakdown of aggrecan 36.

Expression of MMPs is generally low in normal cells which allows for healthy tissue turnover. On the other hand, the level of MMPs increases substantially under pathological conditions and results in ECM degradation. A single nucleotide polymorphism (SNP) for guanine insertion/deletion (G/D) at position -1607 in the promoter region of the MMP1 gene (-1607 polymorphism) results in creation of binding sites for Ets transcription factor family 29. Upon the interaction of adjacent AP-1 site, the promoter activity and hence the transcription level of MMP1 can be considerably increased 2930.

In the present study, the association between this promoter SNP and DDD was investigated in a population-based dataset 1422. We demonstrated significant association with DDD and the deletion of guanine is suggested to be a possible genetic risk factor predisposing to DDD.

Methods

Subjects & assessment

The study was approved by the local ethics committee and informed consent was obtained. Individuals of Southern Chinese origin were recruited by open invitation from the general population. All the recruited subjects subsequently underwent magnetic resonance imaging (MRI) of the lumbar spine and their blood was obtained for DNA extraction and genotyping analysis.

The MRI examinations were performed at the Jockey Club MRI Engineering Centre using a 0.2T Profile open MRI system (General Electric Medical System, Milwaukee, WI). Sagittal T2-weighted fast spin echo sequences (TR = 3000 ms, TE = 92 ms, slice thickness = 5 mm) were used to image the lumbar spine with a built-in flexible body coil. Despite the relative low field, previous studies have demonstrated this to be sensitive enough to identify abnormalities associated with DDD 1422.

DDD was diagnosed on the basis of signal intensity changes within the nucleus pulposus (NP) of the intervertebral discs (IVDs) of the lumbar spine and graded using the Schneiderman's classification scheme 37. Grade 0 was used to indicate normal disc with hyperintense signal within the NP, grade 1 for a slight decrease in signal intensity in the NP, grade 2 for a generalized hypointense NP and grade 3 for a hypointense NP with disc space narrowing. All the MRI scans were analyzed and rated by two experienced physicians blinded to the results of the genetic analysis and clinical history. Differences were reviewed by the two raters and settled by consensus. The score for each disc (0–3) was then summated to create a DDD score for the whole lumbar spine (0–15) as previously described 14. To define the affection status using DDD score, a score of 0 was used to indicate the absence of disc degeneration, while a score of 2 or above was used to indicate the presence of degeneration. Individuals with DDD score of 1 are considered as borderline degeneration and was the area of the majority of disagreements between the 2 raters and hence those with DDD score of 1 was considered unknown affection status and excluded from analysis 1422.

Disc bulge was defined in discs where it has protruded posteriorly beyond a line connecting the posterior margins of the adjacent vertebral bodies. In addition, annular tears and Schmorl's nodes were assessed 14. Annular tears were defined as areas of high signal intensity within the posterior annulus surrounded by a dark rim. Schmorl's nodes were defined as areas of endplate irregularities in which the darkened rim of the vertebral endplate has indented into the vertebral body.

SNP genotyping

Genomic DNA was isolated from the leukocytes and the quality as well as quantity measured by spectrophotometry. Genotyping was performed using the Sequenom^®platform. The Mass ARRAY AssayDesign software (Sequenom) was used to design amplification and allele-specific extension primers. The extension primer (5'-GTAGTTAAATAATTAGAAAG-3') was designed to hybridize to the amplicon near the SNP site for the extension of a single base or a few bases depending on the genotype of the allele. PCR reactions (Forward primer: 5'-ACGTTGGATGGAACTCACATGTTATGCCAC-3'; Reverse-primer: 5'-ACGTTGGATGCTTCAGTATATCTTGGATTG-3') were set up in 384-well plates at 6 μL total volume per reaction and the reaction mix contains: 5 ng genomic DNA, 0.3 pmol each of specific forward and reverse primers, 200 μM of each dNTP, 3.25 mM MgCl₂and 0.2 unit of HotStarTaq polymerase (5U/μL, Qiagen, Valencia, CA). The PCR condition was: 95°C for 15 min, 45 cycles of 95°C for 20 sec, 56°C for 30 sec and 72°C for 1 min, followed by 72°C for 3 min. The treatment of PCR products with alkaline phosphatase and mass extend reactions were all performed according to manufacturer's (Sequenom) protocol. The final base-extension products were desalted using SpectroClean resin (Sequenom), mixed with 3-hydroxypicolinic acid and analyzed using a modified Brucker Autoflex MALDI-TOF mass spectrometer (Brucker, Billerica, MA).

Statistical analysis

Association and Hardy-Weinberg equilibrium checking were assessed by χ²test and Mann-Whitney U test. Odds ratios and other statistical measures were calculated by SPSS 14.0 software.

Results

A total of 691 individuals were genotyped for the study with 266 males and 425 females. In common with previous studies, no significant differences could be detected in disease predisposition between the 2 genders and therefore no gender stratification was carried out 111314.

Analysis of the D allele showed an over representation in the case group. The D allele conferred a higher risk (1.4 times) of developing DDD when compared to the G allele (P-value = 0.027, odds ratio = 1.41 with 95% CI = 1.04–1.90) (Table 1). Genotypic association on the presence of the D allele was also significantly associated with DDD (P-value = 0.046, odds ratio = 1.50 with 95% CI = 1.01–2.24) (Table 2).

Table 1

Allelic association of DDD with the -1607 polymorphism of MMP1

Total

Age ≤ 40

Age > 40

G (%)

D (%)

G (%)

D (%)

G (%)

D (%)

Control

170 (69.7)

74 (30.3)

31 (67.4)

15 (32.6)

139 (70.2)

59 (29.8)

Case

593 (62.0)

363 (38.0)

143 (62.2)

87 (37.8)

450 (62.0)

276 (38.0)

OR (95% CI)

1.41 (1.04–1.90)

1.26 (0.64–2.46)

1.46 (1.03–2.03)

p value

0.027

0.503

0.033

Note: The G allele is the reference allele of the calculation of ORs.

Table 2

Genotypic association of LDD with the -1607 polymorphism of MMP1

Total

Age ≤ 40

Age > 40

GG (%)

DD/DG (%)

GG (%)

DD/DG (%)

GG (%)

DD/DG (%)

Control

58 (47.5)

64 (52.5)

9 (39.1)

14 (60.9)

49 (49.5)

50 (50.5)

Case

180 (37.7)

298 (62.3)

43 (37.4)

72 (62.6)

137 (37.7)

226 (62.3)

OR (95% CI)

1.50 (1.01–2.24)

1.08 (0.43–2.70)

1.62 (1.03–2.53)

p value

0.046

0.875

0.035

Note: The GG genotype is reference genotype of the calculation of ORs.

Because DDD is age related and 2 risk factors, VDR 14 and the COL9A2 22, have previously been demonstrated to be age-dependent, we also analyzed this MMP1 association to DDD stratified by age group. Using a stratification as in a previous study 14, no significant association was detected in an under-40-year age group (P-value = 0.5, OR = 1.26 with 95% CI = 0.64–2.46). However, in the over-40-year age group, the association was significant (P-value = 0.03, OR = 1.46 with 95% CI = 1.03–2.03) (Tables 1 &2).

In addition, we assessed the difference in the distribution of the DDD score for the D-allele+ (either DD or DG genotype) and D-allele- (GG genotype) groups by Mann-Whitney U test. It was found that the distribution of the DDD score was significantly different between the D-allele+ and D-allele- groups (p value = 0.028) with D-allele+ group having higher DDD score.

Apart from DDD, association was tested on disc bulge, annular tear as well as Schmorl's nodes, no significant association with these phenotypes were found with the MMP1 promoter polymorphism (Table 3).

Table 3

Genotypic association of other degenerative changes with the -1607 polymorphism of MMP1

GG (%)

DD/DG (%)

p value

Disc bulge

Control

122 (42.7)

164 (57.3)

0.316

Case

113 (38.6)

180 (61.4)

Annular tear

Control

215 (41.0)

309 (59.0)

0.430

Case

55 (37.4)

92 (62.6)

Schmorl's node

Control

239 (40.0)

358 (60.0)

0.758

Case

31 (41.9)

43 (58.1)

Discussion

This is the first report of an association of a SNP in the promoter region of MMP1 with DDD. DDD is a complex multifactorial disease. It has been suggested that disc degeneration is highly correlated to age 1538394041 and age stratification was performed in previous studies 1422. Our results indicated that the association of DDD with the SNP is age-dependent, and is associated with subjects over 40 years of age.

MMP1 is involved in the cleavage of fibrillar collagens I, II and III 29303132333435. Type I collagen is found extensively within the annulus fibrosus and bony end-plate, while Type II is the predominant collagen in the inner annulus, nucleus pulposus as well as the cartilaginous end-plate 1627. Previous studies in tumor cell lines showed that an over-representation of the G allele of this promoter SNP resulted in increased MMP1 transcriptional activity, hence more aggressive matrix degradation 29. This was proposed to be a mechanism in cancer progression and was proven in subsequent functional studies which showed that the G allele created additional binding sites for the Ets family of transcription factors 29. These Ets binding sites (-1607 bp) work cooperatively with a nearby AP-1 site (-1602 bp) to enhance promoter activity by at least 2 folds 2930. With the increased promoter activity and hence transcription level, the presence of the G allele could consider to be risk factor for matrix degradation.

Although we found an association with this promoter SNP in MMP1, our result showed the presence of the D allele resulted in an increased risk of DDD, and not the anticipated G allele. Previous in vitro studies have shown that the G allele is associated with higher expression levels of MMP1 2930. Thus, individuals with the D allele with increase risk for DDD could not be explained by increased susceptibility to matrix degradation because there is no over-expression of MMP1.

This association may be explained in a number of ways. First, the frequency for D allele is high in different ethnic populations with 62.5% and 56.7% for African and Caucasian respectively (NCBI database), and 36.4% for Southern Chinese. The high frequency of D allele may indicate that the D allele is a common ancestor allele, which might be in linkage disequilibrium with unknown disease-causing polymorphism within the same gene. Secondly, MMP1 is located in a gene cluster on chromosome 11 with other MMP genes (MMP-3, 7, 8, 10, 12, 13, 20 and 26). It is possible that the observed association is the result of linkage disequilibrium between this MMP1 promoter polymorphism and polymorphisms in other nearby MMP genes. Moreover, despite the Ets binding site can cooperate with AP-1 site to enhance transcription of MMP1, this polymorphism has yet to be tested in intervertebral disc tissues, to see whether it affects the transcription level of MMP1. It maybe that gene expression be differentially displayed in a tissue-specific manner. In addition, expressional activity of MMP1 may also be influenced differentially in response to cytokines and growth factors. Even in the case of cancer, allele corresponding to elevated MMP1 activity (expected to have increased susceptibility to cancer and poor prognosis) was unexpectedly found to have favourable prognosis with colorectal cancer and no association with tumor characteristics 42. Thus further replications of association in other ethnic populations would help substantiate findings in this study.

Conclusion

In summary, we have performed a case-control association study to test for association between this promoter SNP (-1607 polymorphism) of MMP1 and DDD. We have demonstrated this promoter polymorphism was significantly associated with increased susceptibility to DDD in our Southern Chinese population, especially in individuals over 40 years of age. Disc bulge, annular tear as well as Schmorl's nodes were not associated with this polymorphism.

Competing interests

The authors declare that they have no competing interests.

Authors' contributions

YQ, DW, PYP and BJ carried out molecular studies. YQ, DW and KMC drafted the manuscript. JK, KMC, KDK and JCY carried out clinic studies. DW, SPY and PS performed the statistical analysis. YQ, KSE, DC and KMC conceived of the study, and participated in its design and coordination. All authors read and approved the final manuscript.

Acknowledgements

The authors thank Pei Yu, Woo Yuk Kuen, Mavis Yiu, and Iris Lee for their expert technical assistance. The authors also thank The Hong Kong Jockey Club MRI Center and the Genome Research Centre, The University of Hong Kong for the use of their facilities. This work was supported by grants from the University Grants Committee of Hong for Kong (AoE/M-04/04) and the Research Grants Council of Hong Kong (HKU7509/03 M).

Epidemiological features of chronic low-back pain Andersson GB Lancet 1999 354 581 585 10.1016/S0140-6736(99)01312-4 10470716 The association of lumbar disc disease with vitamin-D receptor gene polymorphism Kawaguchi Y Kanamori M Ishihara H Ohmori K Matsui H Kimura T J Bone Joint Surg Am 2002 84-A 11 2022 2028 12429765 Recurrent low back pain and early disc degeneration in the young Salminen JJ Erkintalo MO Pentti J Oksanen A Kormano MJ Spine 1999 24 1316 1321 10.1097/00007632-199907010-00008 10404573 Is degenerative disk disease genetically determined? Rannou F Revel M Poiraudeau S Joint Bone Spine 2003 70 3 5 10.1016/S1297-319X(02)00003-9 12639610 Intragenic polymorphisms of the vitamin D receptor gene associated with intervertebral disc degeneration Videman T Leppavuori J Kaprio J Battie MC Gibbons LE Peltonen L Koskenvuo M Spine 1998 23 2477 2485 10.1097/00007632-199812010-00002 9854746 Low back pain Deyo RA Weinstein JN N Engl J Med 2001 344 363 370 10.1056/NEJM200102013440508 11172169 Fibronectin and its fragments increase with degeneration in the human intervertebral disc Oegema TR Jr Johnson SL Aguiar DJ Ogilvie JW Spine 2000 25 2742 2747 10.1097/00007632-200011010-00005 11064518 Acute prolapsed lumbar intervertebral disc. An epidemiologic study with special reference to driving automobiles and cigarette smoking Kelsey JL Githens PB O'Conner T Weil U Calogero JA Holford TR White AA 3rd Walter SD Ostfeld AM Southwick WO Spine 1984 9 608 613 10.1097/00007632-198409000-00012 6495031 Effects of continuous quantitative vibration on rheologic and biological behaviors of the intervertebral disc Ishihara H Tsuji H Hirano N Ohshima H Terahata N Spine 1992 17 3 Suppl S7 12 1566190 Vibration of the spine and low back pain Pope MH Hansson TH Clin Orthop Relat Res 1992 279 49 59 1534724 1991 Volvo Award in clinical sciences. Smoking and lumbar intervertebral disc degeneration: an MRI study of identical twins Battie MC Videman T Gill K Moneta GB Nyman R Kaprio J Koskenvuo M Spine 1991 16 1015 1021 10.1097/00007632-199109000-00001 1948392 Genetics of disc degeneration Chan D Song Y Sham P Cheung KM Eur Spine J 2006 15 317 325 10.1007/s00586-006-0171-3 The relative roles of intragenic polymorphisms of the vitamin d receptor gene in lumbar spine degeneration and bone density Videman T Gibbons LE Battie MC Maravilla K Vanninen E Leppavuori J Kaprio J Peltonen L Spine 2001 26 3 E7 E12 10.1097/00007632-200102010-00003 11224872 Association of the Taq I allele in vitamin D receptor with degenerative disc disease and disc bulge in a Chinese population Cheung KM Chan D Karppinen J Chen Y Jim JJ Yip SP Ott J Wong KK Sham P Luk KD Cheah KS Leong JC Song YQ Spine 2006 31 1143 1138 10.1097/01.brs.0000216530.41838.d3 16648751 The association of degeneration of the intervertebral disc with 5a/6a polymorphism in the promoter of the human matrix metalloproteinase-3 gene Takahashi M Haro H Wakabayashi Y Kawa-uchi T Komori H Shinomiya K J Bone Joint Surg Br 2001 83 491 495 10.1302/0301-620X.83B4.11617 11380116 Molecular biology of degenerative disc disease Guiot BH Fessler RG Neurosurgery 2000 47 1034 1040 10.1097/00006123-200011000-00003 11063096 Matrix metalloproteinases and aggrecanase: their role in disorders of the human intervertebral disc Roberts S Caterson B Menage J Evans EH Jaffray DC Eisenstein SM Spine 2000 25 3005 3013 10.1097/00007632-200012010-00007 11145811 Magnetic resonance imaging findings in relation to the COL9A2 tryptophan allele among patients with sciatica Karppinen J Paakko E Raina S Tervonen O Kurunlahti M Nieminen P Ala-Kokko L Malmivaara A Vanharanta H Spine 2002 27 78 83 10.1097/00007632-200201010-00018 11805640 Identification of a novel common genetic risk factor for lumbar disk disease Paassilta P Lohiniva J Goring HH Perala M Raina SS Karppinen J Hakala M Palm T Kroger H Kaitila I Vanharanta H Ott J Ala-Kokko L JAMA 2001 285 1843 1849 10.1001/jama.285.14.1843 11308397 An allele of COL9A2 associated with intervertebral disc disease Annunen S Paassilta P Lohiniva J Perala M Pihlajamaa T Karppinen J Tervonen O Kroger H Lahde S Vanharanta H Ryhanen L Goring HH Ott J Prockop DJ Ala-Kokko L Science 1999 285 409 412 10.1126/science.285.5426.409 10411504 COL9A3 gene polymorphism and obesity in intervertebral disc degeneration of the lumbar spine: evidence of gene-environment interaction Solovieva S Lohiniva J Leino-Arjas P Raininko R Luoma K Ala-Kokko L Riihimaki H Spine 2002 27 2691 2696 10.1097/00007632-200212010-00008 12461395 The TRP2 allele of COL9A2 is an age-dependent risk factor for the development and severity of intervertebral disc degeneration Jim JJ Noponen-Hietala N Cheung KM Ott J Karppinen J Sahraravand A Luk KD Yip SP Sham PC Song YQ Leong JC Cheah KS Ala-Kokko L Chan D Spine 2005 30 2735 2742 10.1097/01.brs.0000190828.85331.ef 16371896 Collagen type I alpha1 Sp1 polymorphism, osteoporosis, and intervertebral disc degeneration in older men and women Pluijm SM van Essen HW Bravenboer N Uitterlinden AG Smit JH Pols HA Lips P Ann Rheum Dis 2004 63 71 77 1754707 14672895 10.1136/ard.2002.002287 Association of a COL1A1 polymorphism with lumbar disc disease in young military recruits Tilkeridis C Bei T Garantziotis S Stratakis CA J Med Genet 2005 42 e44 10.1136/jmg.2005.033225 15994869 A functional SNP in CILP, encoding cartilage intermediate layer protein, is associated with susceptibility to lumbar disc disease Seki S Kawaguchi Y Chiba K Mikami Y Kizawa H Oya T Mio F Mori M Miyamoto Y Masuda I Tsunoda T Kamata M Kubo T Toyama Y Kimura T Nakamura Y Ikegawa S Nat Genet 2005 37 607 612 10.1038/ng1557 15864306 Association between an aggrecan gene polymorphism and lumbar disc degeneration Kawaguchi Y Osada R Kanamori M Ishihara H Ohmori K Matsui H Kimura T Spine 1999 24 2456 2460 10.1097/00007632-199912010-00006 10626307 Matrix metalloproteinases: the clue to intervertebral disc degeneration? Goupille P Jayson MI Valat JP Freemont AJ Spine 1998 23 1612 1626 10.1097/00007632-199807150-00021 9682320 Intervertebral disk degeneration and herniation: the role of metalloproteinased and cytokines Grange L Gaudin P Trocme C Phelip X Morel F Juvin R Joint Bone Spine 2001 68 547 553 10.1016/S1297-319X(01)00324-4 11808997 A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter creates an Ets binding site and augments transcription Rutter JL Mitchell TI Buttice G Meyers J Gusella JF Ozelius LJ Brinckerhoff CE Cancer Res 1998 58 5321 5325 9850057 A single nucleotide polymorphism in the matrix metalloproteinase-1 (MMP-1) promoter influences amnion cell MMP-1 expression and risk for preterm premature rupture of the fetal membranes Fujimoto T Parry S Urbanek M Sammel M Macones G Kuivaniemi H Romero R Strauss JF 3rd J Biol Chem 2002 277 6296 6302 10.1074/jbc.M107865200 11741975 Transcriptional regulation of collagenase (MMP-1, MMP-13) genes in arthritis: integration of complex signaling pathways for the recruitment of gene-specific transcription factors Vincenti MP Brinckerhoff CE Arthritis Res 2002 4 3 157 64 128926 12010565 10.1186/ar401 The involvement of matrix metalloproteinases and inflammation in lumbar disc herniation Matsui Y Maeda M Nakagami W Iwata H Spine 1998 23 8 863 8 10.1097/00007632-199804150-00005 9580952 Fra-1 targets the AP-1 site/2G single nucleotide polymorphism (ETS site) in the MMP-1 promoter Tower GB Coon CI Belguise K Chalbos D Brinckerhoff CE Eur J Biochem 2003 270 20 4216 25 10.1046/j.1432-1033.2003.03821.x 14519134 High levels of MMP-1 expression in the absence of the 2G single nucleotide polymorphism is mediated by p38 and ERK1/2 mitogen-activated protein kinases in VMM5 melanoma cells Benbow U Tower GB Wyatt CA Buttice G Brinckerhoff CE J Cell Biochem 2002 86 2 307 19 10.1002/jcb.10225 12112000 Erk 1/2 differentially regulates the expression from the 1G/2G single nucleotide polymorphism in the MMP-1 promoter in melanoma cells Tower GB Coon CC Benbow U Vincenti MP Brinckerhoff CE Biochim Biophys Acta 2002 1586 3 265 74 11997078 Fibroblast and neutrophil collagenases cleave at two sites in the cartilage aggrecan interglobular domain Fosang AJ Last K Knauper V Neame PJ Murphy G Hardingham TE Tschesche H Hamilton JA Biochem J 1993 295 273 6 1134849 8216228 Magnetic resonance imaging in the diagnosis of disc degeneration: correlation with discography Schneiderman G Flannigan B Kingston S Thomas J Dillin WH Watkins RG Spine 1987 12 276 281 10.1097/00007632-198704000-00016 2954224 Prevalence of lumbar disk degeneration observed by magnetic resonance in symptomless women Powell MC Wilson M Szypryt P Symonds EM Worthington BS Lancet 1986 2 1366 1367 10.1016/S0140-6736(86)92008-8 2878228 Intervertebral disk: normal age-related changes in MR signal intensity Sether LA Yu S Haughton VM Fischer ME Radiology 1990 177 385 388 2217773 Progressive and regressive changes in the nucleus pulposus. Part II. The adult Yu SW Haughton VM Ho PS Sether LA Wagner M Ho KC Radiology 1988 169 93 97 3420285 Disc degeneration in magnetic resonance imaging. A comparative biochemical, histologic, and radiologic study in cadaver spines Tertti M Paajanen H Laato M Aho H Komu M Kormano M Spine 1991 16 629 634 10.1097/00007632-199106000-00006 1862401 The collagenase-I (MMP-1) gene promoter polymorphism -1607/2G is associated with favourable prognosis in patients with colorectal cancer Hettiaratchi A Hawkins NJ McKenzie G Ward RL Hunt JE Wakefield D Girolamo ND Br J Cancer 2007 96 783 92 10.1038/sj.bjc.6603630 17311017

Pre-publication history

The pre-publication history for this paper can be accessed here:

http://www.biomedcentral.com/1471-2350/9/38/prepub